AARD Financials
Aardvark Therapeutics Inc - Financial statements & key metrics
Stock Price
$15.52
Market Cap
$334.66M
EPS
$-2.53
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$0.00
Gross Profit
$-16000.00
Operating Income
$-22.79M
Net Income
$-20.59M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$77.51M
Total Liabilities
$132.15M
Shareholders Equity
$-54.64M
Cash & Equivalents
$61.64M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-18.09M
CapEx
$109000
Free Cash Flow
$-18.20M
Profitability Metrics
ROE
-0.5%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is AARD revenue?
AARD's most recent quarterly revenue was $0.00. Annual revenue can be calculated by summing the four most recent quarters.
Is AARD profitable?
AARD reported a loss of $20.59M in the most recent quarter.
What is AARD market cap?
AARD has a market capitalization of $334.66M, making it a small-cap stock.
Does AARD have debt?
View AARD's balance sheet for debt information.
What is AARD cash flow?
AARD's most recent quarterly free cash flow was $-18.20M.